Events2nd Canadian Peptide and Protein Community Virtual Meeting
Published
This submission belongs to the session Posters. Poster Session of the event 2nd Canadian Peptide and Protein Community Virtual Meeting
Published date
04 Nov, 2024
Academic Editor
author-avatarWilliam D. Lubell
Citation
Raphael Onuku, Akachukwu Ibezim, Chidalu Ottih, Ifeoma Ezeonu, Efeturi Onoabedje, Ramanathan Karuppasamy, Ngozi Nwodo, New Sulphonamide-peptide Hybrid Molecules as Potential PBP 2a Ligands and Methicillin Resistant Staphylococcus aureus Actives, in Proceedings of 2nd Canadian Peptide and Protein Community Virtual Meeting, 16 December 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

New Sulphonamide-peptide Hybrid Molecules as Potential PBP 2a Ligands and Methicillin Resistant Staphylococcus aureus Actives

image
Chidalu Ottih 3
Ifeoma Ezeonu 3
1. Department of Medicinal Chemistry, University of Michigan, Ann Arbor; Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nigeria
2. Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nigeria
3. Department of Microbiology, University of Nigeria, Nsukka, Nigeria
4. Department of Pure and Industrial Chemistry, University of Nigeria, Nsukka, Nigeria
5. Department of Biotechnology, Vellore Institute of Technology, Vellore, Tamilnadu, India, India
Abstract

Penicillin-binding protein 2a (PbP 2a) expression accounts for the insusceptibility of methicillin-resistant Staphylocuccus aureus (MRSA) to β-lactam antibiotics. In this research, we employed computational strategies to challenge PbP 2a with series of fifty-five ‘ala-ala’ and ‘ala-pro’ sulphonamide-dipeptides. The binding stability of two compounds (labeled: 10i and 10n) with theoretical Ki in nM and μM ranges, for PbP 2a active and allosteric sites respectively, were investigated using molecular dynamics simulations. In addition, the results of the sensitivity of four strains of MRSA for compounds 10i and 10n obtained revealed the compounds at 10 μg/ml caused two isolates (S4 and S10) to revert to being susceptible. Finally, a reliable binding conformation of both compounds in the two binding sites of PbP 2a are described to provide a rationale for structure-activity optimization of this series.

Keywords
Sulphonamides
peptides
PbP 2a
MRSA
molecular docking
molecular dynamics
simulation
binding mode prediction
protein-ligand interaction
CONCEPTION OF COVALENTLY REVERSIBLE semi-PEPTIDIC INHIBITORS OF TMPRSS2 FOR SARS-COV-2 TREATMENT
Evaluation of in vitro activity of C. neoformans isolated from hospital samples with synthetic peptides